✦ LIBER ✦

P2022 Clinical and bacteriological efficacy of sequential intravenous to oral moxifioxacin in hospitalised patients with community–acquired pneumonia due to Enterobacteriaceae

✍ Scribed by Choudhri, S.; Arvis, P.; Haverstock, D.

Book ID: 122602829
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 59 KB
Volume: 29
Category: Article
ISSN: 0924-8579
DOI: 10.1016/S0924-8579(07)71861-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P2021 Clinical and bacteriological effic

P2021 Clinical and bacteriological efficacy of sequential intravenous to oral moxifioxacin in hospitalised patients with community–acquired pneumonia and pneumococcal bacteraemia

✍ Choudhri, S.; Arvis, P.; Haverstock, D. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 68 KB

P2023 Clinical and bacteriological effic

P2023 Clinical and bacteriological efficacy of sequential intravenous to oral moxifioxacin in hospitalised patients with severe complicated skin and skin structure infections due to Enterobacteriaceae

✍ Bogner, J.R.; Choudhri, S.H.; Arvis, P.; Pertel, P.; Breilmann, J-M. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Randomized, Double-Blind, Multicenter Ph

Randomized, Double-Blind, Multicenter Phase 2 Study Comparing the Efficacy and Safety of Oral Solithromycin (CEM-101) to Those of Oral Levofloxacin in the Treatment of Patients with Community-Acquired Bacterial Pneumonia

✍ Oldach, D.; Clark, K.; Schranz, J.; Das, A.; Craft, J. C.; Scott, D.; Jamieson, 📂 Article 📅 2013 🏛 American Society for Microbiology 🌐 English ⚖ 253 KB